Amphastar Pharmaceuticals (AMPH) Return on Capital Employed Growth (1y) (2015 - 2026)
Amphastar Pharmaceuticals (AMPH) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 933.33 Mn | 643.20 Mn | 93.47 Mn | -460.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -460.00 |
| Mar 31, 2026 | -596.00 |
| Dec 31, 2025 | -538.00 |
| Sep 30, 2025 | -532.00 |
| Jun 30, 2025 | -389.00 |
| Mar 31, 2025 | -254.00 |
| Dec 31, 2024 | -31.00 |
| Sep 30, 2024 | 74.00 |
| Jun 30, 2024 | 54.00 |
| Mar 31, 2024 | -187.00 |
| Dec 31, 2023 | -170.00 |
| Sep 30, 2023 | -5.00 |
| Jun 30, 2023 | 44.00 |
| Mar 31, 2023 | 428.00 |
| Dec 31, 2022 | 428.00 |
| Sep 30, 2022 | 642.00 |
| Jun 30, 2022 | 1,036.00 |
| Mar 31, 2022 | 1,132.00 |
| Dec 31, 2021 | 1,038.00 |
| Mar 31, 2021 | 56.00 |